Insider Stock Trading History of Mirza Mansoor Raza


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mirza Mansoor Raza since year 2005. The trader's CIK number is 1588389. At the time of this reporting, Mirza Mansoor Raza is the Director of Karyopharm Therapeutics Inc. . (stock ticker symbol KPTI). See this page for all insider trading activities at Karyopharm Therapeutics Inc. .


Stock purchases, sales, and option exercises reported by insider Mirza Mansoor Raza since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-02 KPTI Karyopharm Therapeutics Inc. Option Ex 2,000 .26 528
2017-10-02 KPTI Karyopharm Therapeutics Inc. Sale 2,000 12.00 24,000
2017-09-15 KPTI Karyopharm Therapeutics Inc. Option Ex 2,882 .26 760
2017-09-15 KPTI Karyopharm Therapeutics Inc. Sale 2,882 11.00 31,702
2017-09-11 KPTI Karyopharm Therapeutics Inc. Sale 118 11.00 1,298
2017-09-11 KPTI Karyopharm Therapeutics Inc. Option Ex 118 .26 31
2015-12-08 KPTI Karyopharm Therapeutics Inc. Sale 15,000 15.01 225,135
2015-12-08 KPTI Karyopharm Therapeutics Inc. Option Ex 10,738 .11 1,181
2014-12-01 KPTI Karyopharm Therapeutics Inc. Option Ex 1,535 .03 50
2014-12-02 KPTI Karyopharm Therapeutics Inc. Option Ex 5,000 .03 165
2014-12-01 KPTI Karyopharm Therapeutics Inc. Sale 5,000 41.86 209,285
2014-12-02 KPTI Karyopharm Therapeutics Inc. Sale 5,000 45.18 225,880
2014-11-10 KPTI Karyopharm Therapeutics Inc. Sale 5,000 45.05 225,255
2014-11-03 KPTI Karyopharm Therapeutics Inc. Sale 5,000 40.95 204,750
2014-10-29 KPTI Karyopharm Therapeutics Inc. Sale 3,500 40.05 140,161
2014-10-20 KPTI Karyopharm Therapeutics Inc. Sale 1,500 35.04 52,560

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mirza Mansoor Raza (Director of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.